AIHealthcare

C3 AI, Inc. is a publicly traded enterprise artificial intelligence software company that develops an end-to-end platform for building, deploying, and operating enterprise AI applications. Its offerings include the C3 Agentic AI Platform, industry-specific AI applications, and C3 Generative AI applications. Healthcare is one of its target markets: C3 AI connects clinical, claims, and research data to support care improvement, research, and operational workflows. The company’s market position is that of a large-enterprise-focused AI application and platform vendor serving sectors including healthcare, government, defense, energy, manufacturing, and financial services. It trades on the New York Stock Exchange under the symbol AI and completed its IPO in December 2020. For the fiscal year ended April 30, 2026, it reported $250.3 million in revenue, including $227.1 million in subscription revenue, and held $673 million in cash, cash equivalents, and marketable securities as of June 3, 2026. The available sources do not identify a recent venture funding round; C3 AI is financed primarily through operating sales, public equity issuance, employee stock-plan proceeds, and its IPO.